CLASS ACTION LAWSUIT UPDATE: Brodsky & Smith, LLC Is Investigating Securities Violations by the Following Companies: KPTI, IFF, PS

BALA CYNWYD, PA / ACCESSWIRE / September 12, 2019 / Brodsky & Smith, LLC is investigating class action lawsuits against the following companies for violations of federal securities laws. If you purchased any of the below-listed stocks during the referenced time periods and want to discuss your legal rights, please contact Marc Ackerman, Esquire or Jordan Schatz, Esquire at 877-534-2590. There is no cost or financial obligation to you.

KARYOPHARM THERAPEUTICS, INC. (Nasdaq:KPTI)

Shares purchased between March 2, 2017 and February 22, 2019

Deadline: September 23, 2019

According to the complaint, defendants made materially false and/or misleading statements and/or failed to disclose that: Throughout the Class Period, the Company continued to tout the commercial prospects for selinexor and consistently described selinexor as having a “predictable and manageable tolerability profile” and a “very nice safety profile,” and assured investors that it was “well tolerated” by patients. Karyopharm also claimed that selinexor had the potential to be used as a new treatment for MM, with limited and manageable side effects. As a result of these misrepresentations, Karyopharm shares traded at artificially inflated prices during the Class Period.

Additional information can be found at: http://www.brodskysmith.com/cases/karyopharm-therapeutics-inc-nasdaq-kpti/, or call: 877-534-2590. No cost or obligation.

INTERNATIONAL FLAVORS AND FRAGRANCES INC. (NYSE:IFF)

Shares purchased between May 7, 2018 and August 5, 2019

Deadline: October 11, 2019

According to the filed complaint, IFF made materially false and/or misleading statements and/or failed to disclose that: (1) that Frutarom Industries Ltd. ("Frutarom"), which the Company acquired in 2018, had bribed customers in Russia and Ukraine; (2) that senior management at Frutarom were aware of such improper payments; (3) that, as a result, Frutarom’s financial results were materially overstated; (4) that, as a result of the improper payments, the Company was reasonably likely to face regulatory scrutiny; (5) that the Company had not completed adequate due diligence before acquiring Frutarom; (6) that, as a result of the foregoing, the Company was unlikely to achieve purported synergies from the acquisition; and (7) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Additional information can be found at http://www.brodskysmith.com/cases/international-flavors-fragrances-inc-nyse-iff/ or call 877-534-2590. No cost or obligation to you.

PLURALSIGHT, INC. (NASDAQ:PS)

Shares purchased between August 2, 2018 and July 31, 2019

Deadline: October 15, 2019

According to the filed complaint, the Company made false and misleading statements to the market. Pluralsight failed to execute on its sales strategies, which impacted its billing to customers. The Company also suffered from delays in hiring and training an effective salesforce to meet its financial projections. Pluralsight fell behind in onboarding new sales reps, which compounded the execution problems already plaguing the organization. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Pluralsight, investors suffered damages.

Additional information can be found at http://www.brodskysmith.com/cases/pluralsight-inc-nasdaq-ps/ or call 877-534-2590. No cost or obligation to you.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

SOURCE: Brodsky & Smith, LLC